I'll write the friggin release.
''BTA is pleased to advise that GSK has indicated it is increasing its Production capacity to 190 million packs.
The plans include a commitment by GSK to increase its annual production capacity of the influenza anti-viral Relenza to 190 million courses by the end of 2009. This increase represents a threefold increase to GSK�fs previous increased capacity of 60 million courses.
'Going forward BTA looks forward to an increased revenue stream due to this increased production.'' said a delighted Peter Cook.
GSK has confirmed to BTA that they have solid orders received that supports this increased production.""
Disclaimer (This is make beleive)
- Forums
- ASX - By Stock
- BTA
- bta ann. is coming.
bta ann. is coming., page-16
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)